Where are we with Stem Cells? Hadassah Pioneer Brings Us Up to Date

Tuesday, Apr 17 2018

Prof. Benjamin Reubinoff, MD, PhD

Many diseases involve the malfunctioning or dying of cells within the body. Can these cells be replenished or replaced to alleviate the suffering of those with debilitating conditions such as multiple sclerosis, age-related macular degeneration, Parkinson’s disease, and diabetes?

Do adult stem cells or embryonic stem cells hold the answer? Where are we in renewing our cells or replacing dying ones with new ones?  What exactly is the state of the art? Are there caveats in seeking stem cell treatment today?

Trailblazing new frontiers in medicine, Prof. Benjamin Reubinoff, MD, PhD, Director of the Human Embryonic Stem Cell Research Center at the Hadassah Medical Organization, addresses these questions in two illuminating and inspirational podcasts. Listen now:


The Exciting Future of Stem Cells, Part 1

The Exciting Future of Stem Cells, Part 2

Other interviews are available on our new podcast series Hadassah on Call: New Frontiers in Medicine.  Each episode takes you behind the headlines with Hadassah Medical Organization doctors and specialists, patients and nurses.


No comments yet.
First Name
Enter this word:

Related Stories


Monday, May 7 2018

Pluristem Stem Cell Therapy, Based on Hadassah Preclinical Research, Has Been Cleared by FDA

Pluristem Therapeutics has announced that its new cell therapy to treat acute radiation syndrome (PLX-R18), based on the pioneering studies performed within the laboratory of Prof. Raphael Gorodetsky at the Hadassah Medical Organization, has received clearance from the United States Food and Drug Administration to treat individuals who may have been acutely exposed to high-dose radiation as the result of a nuclear attack or accident.


Monday, May 7 2018

Hadassah Cardiac Specialists Are Collaborating with Colleagues to Save Syrian Children

In an effort to save the lives of Syrian children suffering from life-threatening and complex heart abnormalities, the Hadassah Medical Organization and the Baruch Padeh Medical Center in Poriya-Tiberias have launched a unique collaboration as part of the Israel Defense Forces’ Good Neighbor program.


Thursday, May 3 2018

HMO Exclusive Call with Nurse Rely Alon

Please join us for an exclusive conference call with Dr. Rely Alon, Director, Division of Nursing & Health Professions, Wednesday May 9, 2018 from 10:00 - 11:00 am EDT


Tuesday, Apr 17 2018

Predicting Clinical Outcomes for Multiple Sclerosis Patients: Cutting-Edge Research at Hadassah

More than two million people--two to three times more women--have multiple sclerosis (MS)--the leading cause of neurological disability among young adults. What is their prognosis?


Donation Questions


(800) 928-0685

Membership Questions


(800) 664-5646

Missions Department


(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005


More ›

Show More